variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
GBA-L483P,GBA,"Causes Gaucher's disease, a recessive disorder whose symptoms include anemia, bruising, bone lesions, and spleen and liver issues. Reported to ClinVar by OMIM and Emory Genetics Laboratory (http://www.ncbi.nlm.nih.gov/clinvar/RCV000004509/), numerous publications cite this variant as causing the disease.",High,Likely,Pathogenic,,"Blood;Mouth, liver, and digestive;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
MBL2-R52C,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele D. See G54D (variant B) and G57E (variant C).",Low,Likely,Pathogenic,0.049,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs5030737,1,chr10,54531242,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
TLR5-R392X,TLR5,"This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.",Low,Uncertain,Pathogenic,0.044,Immune system,Complex/Other,Heterozygous,14623910;16027372;17516623;18230059,rs5744168,1,chr1,223285200,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
CFB-R32Q,CFB,"This variant is associated with a significant protective effect -- individuals with this variant are about half as likely to have age-related macular degeneration. Appears to be an additive effect, with homozygotes having a stronger protective effect.",Moderate,Likely,Protective,0.12,Hearing and vision,Dominant,Heterozygous,16518403;16936732;19117936,rs641153,3,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
DTNBP1-P272S,DTNBP1,Possibly a slight protective effect against colorectal cancer if homozygous.,Low,Uncertain,Protective,0.035,Cancer,Recessive,Heterozygous,17000706,rs17470454,2,chr6,15523448,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
NOTCH3-H1133Q,NOTCH3,Probably benign.,Low,Uncertain,Benign,0.013,Other,Unknown,Heterozygous,9388399,rs112197217,,chr19,15290236,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
MUSK-T100M,MUSK,Probably benign.,Low,Uncertain,Benign,0.023,Other,Unknown,Heterozygous,,rs35142681,,chr9,113449489,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
KRT85-R78H,KRT85,"Presumed benign. Although this variant was implicated in causing ectodermal dysplasia in a recessive manner in two Pakistani families (one of which was large and consanguineous), GET-Evidence reports that the variant has been seen in 5 out of 114 random control chromosomes. This strongly contradicts a severe pathogenic effect.",Low,Uncertain,Benign,0.042,Skin,Recessive,Heterozygous,16525032;19865094,rs61630004,,chr12,52760957,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
FANCA-S1088F,FANCA,"Probably benign. One report hypothesized this variant causing Fanconi Anemia, but the allele frequency (3-7%) is high enough to contradict a highly penetrant pathogenic effect. Later authors have concluded this is a polymorphism, not pathogenic.",Low,Uncertain,Benign,0.058,Blood,Unknown,Heterozygous,10094191;14695169,rs17233497,0,chr16,89815152,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
PALB2-E672Q,PALB2,Probably benign.,Low,Uncertain,Benign,0.024,Other,Unknown,Heterozygous,17200668,rs45532440,,chr16,23641461,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Homozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=ec2f3e829957bd0ca1ab63a048b236e573ce6e82&access_token=3d6d6b97dec2fc57fa122114da4efc10
